The global Digital Biomarkers (DBM) Market experienced robust growth, with its size reaching USD 1.86 Billion in 2022, and is projected to continue expanding at a remarkable revenue CAGR of 36.6% during the forecast period. This surge in market revenue can be attributed to the increasing utilization of digital biomarkers in therapeutics, particularly in treating gastrointestinal disease, neurodegenerative diseases, cardiovascular diseases, and other chronic conditions. The prevalence of these chronic diseases has risen due to the global increase in the elderly population.
https://www.reportsanddata.com/report-detail/digit
Like
Comment
Share
